168 related articles for article (PubMed ID: 38541745)
1. Extra-Anogenital Giant Cutaneous Squamous Cell Carcinomas.
Mateuszczyk MK; Chlebicka I; Łyko M; Maj J; Szepietowski JC
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541745
[TBL] [Abstract][Full Text] [Related]
2. Extra-anogenital giant cutaneous squamous cell carcinomas require multidisciplinary management.
van Dam V; Trinh XB; An B; Julien L
Cancer Treat Res Commun; 2021; 28():100413. PubMed ID: 34126577
[TBL] [Abstract][Full Text] [Related]
3. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P
Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma.
Paul E; Konidaris G; Cope S; Chen CI; Keeping S; Xu Y; Atsou K; Ayers D; Guyot P; Sasane M; Mojebi A; Kuznik A
J Manag Care Spec Pharm; 2021 Nov; 27(11):1513-1525. PubMed ID: 34351214
[No Abstract] [Full Text] [Related]
5. Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives.
Alberti A; Bossi P
Front Oncol; 2021; 11():727027. PubMed ID: 35070956
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
7. The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.
Stanganelli I; Spagnolo F; Argenziano G; Ascierto PA; Bassetto F; Bossi P; Donato V; Massi D; Massone C; Patuzzo R; Pellacani G; Quaglino P; Queirolo P; Zalaudek I; Palmieri G; On Behalf Of Italian Melanoma Intergroup Imi
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053539
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case-control study.
Conde-Ferreirós A; Moyano-Bueno D; Santos-Briz Á; Revelles-Peñas L; Revilla-Nebreda D; Becerril-Andrés S; Román-Curto C; Cañueto J
J Cutan Pathol; 2022 Feb; 49(2):133-138. PubMed ID: 34363705
[TBL] [Abstract][Full Text] [Related]
11. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
12. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
[TBL] [Abstract][Full Text] [Related]
13. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy.
Ferini G; Palmisciano P; Forte S; Viola A; Martorana E; Parisi S; Valenti V; Fichera C; Umana GE; Pergolizzi S
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454779
[TBL] [Abstract][Full Text] [Related]
14. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
Schmitt AR; Brewer JD; Bordeaux JS; Baum CL
JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
[TBL] [Abstract][Full Text] [Related]
15. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
16. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
17. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
18. Surgical management and oncological follow-up of cutaneous squamous cell carcinomas arising in epidermolysis bullosa patients.
Paganelli A; Giordano E; Fiorentini C; Ferrari B; Reggiani C; Garbarino F; Magnoni C
Int J Dermatol; 2022 Oct; 61(10):1171-1174. PubMed ID: 35315931
[TBL] [Abstract][Full Text] [Related]
19. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
